Genetic variants associated with susceptibility to idiopathic pulmonary fibrosis in people of European ancestry: a genome-wide association studyRichard J. Allen, Gísli Jenkins, Robin J. McAnulty et al.|The Lancet Respiratory Medicine|2017Cited by 299
Agonist and Inverse Agonist Actions of β-Blockers at the Human β2-Adrenoceptor Provide Evidence for Agonist-Directed SignalingJillian G. Baker, Stephen J. Hill, Ian P. Hall|Molecular Pharmacology|2003Cited by 187
Chronic obstructive pulmonary disease and related phenotypes: polygenic risk scores in population-based and case-control cohortsMatthew Moll, Rajesh Rawal, Phuwanat Sakornsakolpat et al.|The Lancet Respiratory Medicine|2020Cited by 125
Agonist Actions of “β-Blockers” Provide Evidence for Two Agonist Activation Sites or Conformations of the Human β1-AdrenoceptorJillian G. Baker, Stephen J. Hill, Ian P. Hall|Molecular Pharmacology|2003Cited by 91
Influence of Agonist Efficacy and Receptor Phosphorylation on Antagonist Affinity Measurements: Differences between Second Messenger and Reporter Gene ResponsesJillian G. Baker, Stephen J. Hill, Ian P. Hall|Molecular Pharmacology|2003Cited by 49